ClinicalTrials.Veeva

Menu

The Paternal Clock: Uncovering the Consequences of Advanced Paternal Age on Sperm DNA Fragmentation

O

Ovo Clinic

Status

Completed

Conditions

Infertility, Male

Treatments

Other: Study chart review

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Sperm DNA fragmentation (SDF) serves as a marker for chromatin and DNA damage in sperm. Assessing sperm DNA integrity is crucial in male fertility evaluation since high levels of SDF are associated with a greater number of adverse reproductive outcomes, including an increased risk of miscarriage and birth defects.

Recent research suggests that advanced paternal age (APA) may lead to DNA damage in sperm, however the precise age at which this risk becomes apparent has not yet been clearly defined, necessitating the identification of the point in time at which high SDF levels occur. With the help of this knowledge, male infertility can be diagnosed with greater accuracy, and infertile couples can receive appropriate care.

Enrollment

4,250 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Male of at least 18 years of age

Trial design

4,250 participants in 1 patient group

Men undergoing sperm DNA fragmentation test
Description:
Men presenting at the clinic for infertility evaluation
Treatment:
Other: Study chart review

Trial contacts and locations

1

Loading...

Central trial contact

Nelly Delouya, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems